Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Metastasis × Sorafenib × Clear all

Phase

Status

Completed 18 Unknown 4 Terminated 4 Active not recruiting 2 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Hepatocellular 5 Leukemia, Myeloid, Acute 2 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Locally Advanced Thyroid Gland Carcinoma 1 Liver Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Fibrolamellar hepatocellular carcinoma 1 Breast Neoplasms 1 Adenoma, Islet Cell 1

Interventions

pembrolizumab 43 Specimen Handling 28 Magnetic Resonance Spectroscopy 24 Biopsy 24 Radiosurgery 17 Gemcitabine 14 Nivolumab 12 Cisplatin 11 Paclitaxel 10 Cyclophosphamide 10 Carboplatin 10 Capecitabine 9 Taxes 8 Pemetrexed 8 Leucovorin 8 Irinotecan 8 Fluorouracil 8 Cetuximab 8 Bevacizumab 8 trastuzumab deruxtecan 7 Oxaliplatin 7 Drug Therapy 7 Doxorubicin 7 olaparib 6 cemiplimab 6 abemaciclib 6 Radiotherapy 6 Folfox protocol 6 Docetaxel 6 ribociclib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02029001 2025-08-07

MOST plus

Centre Leon Berard

Phase 2 Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡